RDUS:NSD-Radius Health Inc. (USD)

EQUITY | Steel | NASDAQ Global Market

Last Closing

USD 17.9

Change

0.00 (0.00)%

Market Cap

USD 2.14B

Volume

0.20M

Analyst Target

USD 20.57
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Radius Health Inc is a science-driven biopharmaceutical company engaged in developing new therapeutics for patients with osteoporosis and other serious endocrine-mediated diseases.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-27 )

Largest Industry Peers for Steel

Symbol Name Price(Change) Market Cap
STLD Steel Dynamics Inc

+0.34 (+0.25%)

USD 21.17B
ASTL Algoma Steel Group Inc

-0.13 (-1.65%)

USD 0.82B
ZEUS Olympic Steel Inc

+1.43 (+2.72%)

USD 0.74B
USAP Universal Stainless & Alloy

+1.63 (+5.29%)

USD 0.24B
ACNT Synalloy Corporation

+0.09 (+0.85%)

USD 0.10B
HUDI Huadi International Group Co L..

N/A

USD 0.04B
HLP Hongli Group Inc. Ordinary Sha..

-0.07 (-3.65%)

USD 0.02B
ZKIN ZK International Group Co Ltd

-0.06 (-7.05%)

USD 0.02B
ASTLW Algoma Steel Group Inc. Warran..

-0.11 (-9.48%)

N/A

ETFs Containing RDUS

RWE-B:CA 0.00 % 0.00 %

N/A

N/A
RWE:CA 0.00 % 0.66 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Steel) Market Performance vs. Exchange (NASDAQ Global Market)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -40.65% 10% F 13% F
Dividend Return 1.24% 100% F 65% D
Total Return -39.41% 10% F 13% F
Trailing 12 Months  
Capital Gain 77.58% 90% A- 92% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 77.58% 90% A- 92% A
Trailing 5 Years  
Capital Gain -16.16% 40% F 45% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -16.16% 40% F 40% F
Average Annual (5 Year Horizon)  
Capital Gain 16.03% 50% F 76% C+
Dividend Return 16.03% 50% F 75% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 71.02% 30% F 23% F
Risk Adjusted Return 22.56% 60% D- 59% D-
Market Capitalization 2.14B 67% D+ 63% D

Key Financial Ratios

  Ratio vs. Industry/Classification (Steel) Ratio vs. Market (NASDAQ Global Market)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 65.84 11% 15%
Price/Book Ratio 0.57 78% 87%
Price / Cash Flow Ratio 3.59 78% 41%
Price/Free Cash Flow Ratio 20.97 11% 12%
Management Effectiveness  
Return on Equity -7.17% 20% 52%
Return on Invested Capital -0.10% 20% 60%
Return on Assets -1.08% 20% 52%
Debt to Equity Ratio 26.82% 63% 55%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced on cashflow basis

The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.